Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development

Clin Vaccine Immunol. 2009 Nov;16(11):1675-86. doi: 10.1128/CVI.00224-09. Epub 2009 Sep 30.

Abstract

In a previous study, an apathogenic strain of bovine herpesvirus 4 (BoHV-4) cloned as a bacterial artificial chromosome and expressing a chimeric peptide (gE2/gD) as a secreted form was described. Recombinant virus-inoculated animals produced antibodies against bovine viral diarrhea virus (BVDV) gE2 and BoHV-1 gD. However, neutralizing antibodies were produced only against BVDV, not against BoHV-1. In the present work a recombinant BoHV-4 expressing a membrane-linked form of gE2/gD chimeric peptide was constructed, and inoculated rabbits produced serum-neutralizing antibodies against both BVDV and BoHV-1. Protein cell sorting and targeting are a very important issue when immunodominant antigens are engineered for recombinant virus vaccine development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing / blood*
  • Antibodies, Viral / blood*
  • Antigens, Heterophile / immunology
  • Antigens, Heterophile / metabolism*
  • Diarrhea Viruses, Bovine Viral / genetics
  • Diarrhea Viruses, Bovine Viral / immunology
  • Herpesvirus 4, Bovine / genetics
  • Herpesvirus 4, Bovine / immunology*
  • Protein Transport
  • Rabbits
  • Viral Proteins / immunology
  • Viral Proteins / metabolism*
  • Viral Vaccines / immunology*

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, Heterophile
  • Viral Proteins
  • Viral Vaccines